The elevated level of circulating matrix metalloproteinase-9 in patients with abdominal aortic aneurysms decreased to levels equal to those of healthy controls after an aortic repair

Annals of Vascular Surgery

Volumn 20, Issue 3, 2006, Pages 317-321

  Watanabe, Tetsuo ^a   Sato, Akira ^a   Sawai, Takashi ^b   Uzuki, Miwa ^b   Goto, Hitoshi ^a   Yamashita, Hiroshi ^a   Akamatsu, Daijirou ^a   Sato, Hiroko ^a   Shimizu, Takuya ^a   Miyama, Noriyuki ^a   Nakano, Yoshiyuki ^a   Satomi, Susumu ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; AORTA SURGERY; ARTICLE; BLOOD SAMPLING; CIRCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE CARE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 33745209950     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-006-9038-7     Document Type: Article

References (20)

1. Ailawadi G, Eliason JL, Upchurch GR, Jr. Current concepts in the pathogenesis of abdominal aortic aneurysm. J Vasc Surg 2003;38:584-588.
2. Rizzo RJ, McCarthy WJ, Dixit SN, et al. Collagen types and matrix protein content in human abdominal aortic aneurysms. J Vasc Surg 1989;10:365-373.
3. Baxter BT, Halloran BG. Matrix protein metabolism in abdominal aortic aneurysms In: Yao JST, Pearce WH, eds. Aneurysms. New Findings and Treatments. Nortwalk: Appleton & Lange, 1994, pp 25-34.
4. Carrell TWG, Burnand KG, Wells GMA, et al. Stromelysin-1 (matrix metalloproteinase-3) and tissue inhibitor of metalloproteinase-3 are overexpressed in the wall of abdominal aortic aneurysms. Circulation 2001;105:477-482.
5. Newman KM, Malon AM, Shin RD, et al. Matrix metalloproteinases in abdominal aortic aneurysm: characterization, purification, and their possible sources. Connect Tissue Res 1994;30:265-276.
6. Knox JB, Sukhova GK, Whittemore AD, et al. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 1997;95:205-212.
7. McMillan WD, Patterson BK, Keen RR, et al. In situ localization and quantification of seventy-two-killodalton type IV collagenase in aneurysmal, occlusive and normal aorta. J Vasc Surg 1995;22:295-305.
8. Freestone T, Turner RJ, Coady A, et al. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Atheroscler Thromb Vasc Biol 1995;15:1145-1151.
9. Sakalihansan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet 2005;365:1577-1589.
10. Thompson RW, Holmes DR, Mertens RA, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms: an elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318-326.
11. Sakalihasan N, Delvenne P, Nusgens BV, et al. Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. J Vasc Surg 1996;24:127-133.
12. Longo GM, Xiong W, Greiner TC, et al. Matrix metalloproteinases 2 and 9 work in concert to produce aortic aneurysms. J Clin Invest 2002;110:625-632.
13. Watanabe T, Sawai T, Sato A, et al. The role of matrix metalloproteinases in progression of abdominal aortic aneurysm. J Jpn Coll Angiol 2000;40:505-510.
14. Watanabe T, Sawai T, Sato A, et al. Mapping analysis of the distribution of MMP-2 and MMP-9 in the wall of abdominal aortic aneurysms and correlation with the disruption of elastic fibers. Jpn J Vasc Surg 2000;9:539-544.
15. Tilson MD, Newman KM. Proteolytic mechanisms in the pathogenesis of aortic aneurysms In: Yao, JST, Pearce, WH, eds. Aneurysms. New Findings and Treatments. Norwalk: Appleton & Lange, 1994, pp 3-10.
16. Hovsepian DM, Ziporin SJ, Sakurai MK, et al. Elevated plasma levels of matrix metalloproteinase-9 in patients with abdominal aortic aneurysms: a circulating marker of degenerative aneurysm disease. J Vasc Interv Radiol 2000;11:1345-1352.
17. McMillan WD, Pearce WH. Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. J Vasc Surg 1999;29:122-129.
18. Lindholt JS, Vammen S, Fasting H, et al. The plasma level of matrix metalloproteinase 9 may predict the natural history of small abdominal aortic aneurysms. A preliminary study. Eur J Vasc Endovasc Surg 2000;20:281-285.
19. Seki M, Uzuki M, Ohmoto H, et al. Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis. Ryumachi 1995;35:792-801.
20. Hibbs MS. Expression of 92kDa phagocyte gelatinase by inflammatory and connective tissue cells. Matrix 1992;(Suppl. 1):51-57.